{"nctId":"NCT00573313","briefTitle":"Effects of SAMe in Patients With Alcoholic Liver Disease","startDateStruct":{"date":"2005-09"},"conditions":["Liver Disease, Alcoholic"],"count":94,"armGroups":[{"label":"S-adenosylmethionine (SAMe)","type":"EXPERIMENTAL","interventionNames":["Drug: S-adenosylmethionine"]},{"label":"Sugar pill","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"S-adenosylmethionine","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria\n\n* ALD) a history of chronic alcoholism according to established AUDIT and WHO criteria with the presence of clinical and laboratory features of established liver disease. Also, willingness to undergo liver biopsies at start and completion of the study, and to comply with study medication or placebo and required clinic visits and blood sampling.\n* a history of chronic alcoholism without evidence of liver disease;\n* healthy subjects without history of alcoholism or presence of liver disease.\n\nExclusion Criteria:\n\n* viral Hepatitis B or C\n* hemochromatosis\n* Wilson Disease\n* sclerosing cholangitis\n* primary biliary cirrhosis\n* other chronic disease\n* renal insufficiency","healthyVolunteers":true,"sex":"ALL","minimumAge":"21 Years","maximumAge":"65 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Changes in Serum AST Levels","description":"Biochemical values for liver function tests and histopathology scores were obtained at week 0 and 24 of the treatment trial, and changes in each were recorded. Here are reported changes in aspartate transaminase (AST) as representative of all changes. Since only baseline values were obtained in the Healthy and Lifestyle counseling groups, there are no recorded changes in these two groups.","paramType":"MEDIAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-13.5","spread":"51.344"},{"groupId":"OG001","value":"-56","spread":"18.243"}]}]}]},{"type":"SECONDARY","title":"Changes in Serum SAM","description":"We compared serum levels of SAM at time 0 and week 24 of the study in the alcoholic liver disease groups only, since these parameters were measured in the healthy and lifestyle coaching groups only at baseline.","paramType":"MEDIAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"54","spread":"92.535"},{"groupId":"OG001","value":"7","spread":"150.5"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":18},"commonTop":["Diarrhea","Abdominal bloating","Abdominal pain","Headache","Nausea"]}}}